UChicago Annual Updates from ASH 2019
ASH 2019 Updates on CAR T Cell Therapy in DLBCL: Liso-cel has Favorable Safety Profile With Low Rates of Severe CRS/ICANS
By
UChicago Annual Updates from ASH 2019
FEATURING
Peter Riedell
By
UChicago Annual Updates from ASH 2019
FEATURING
Peter Riedell
Login to view comments.
Click here to Login